Live from the NIH registry
Studies recruiting near El Paso right now
Top 25 of 191 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50781 — El Paso, Texas (7.0 mi)
· Sponsor: UCB Biopharma SRL
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Advanced Neurology Epilepsy and Sleep Center/ANESC Research — El Paso, Texas (7.0 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
El Paso Pulmonary Association — El Paso, Texas (7.0 mi)
· Sponsor: Philip Morris Products S.A.
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Renovatio Clinical - El Paso — El Paso, Texas (7.0 mi)
· Sponsor: Hoffmann-La Roche
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
El Paso Pulmonary Association- Site Number : 8400033 — El Paso, Texas (7.0 mi)
· Sponsor: Sanofi
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: National Cancer Institute (NCI)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: PedAL BCU, LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Academy of Diabetes, Thyroid and Endocrine /ID# 255735 — El Paso, Texas (7.0 mi)
· Sponsor: AbbVie
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3
Interventional 161 participants sought
Advanced Neurology Epilepsy and Sleep Center/ANESC Research — El Paso, Texas (7.0 mi)
· Sponsor: Kedrion S.p.A.
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Schizophrenia
N/A
Observational 300 participants sought
Haracec Clinical Research — El Paso, Texas (7.0 mi)
· Sponsor: Bristol-Myers Squibb
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — El Paso, Texas (7.0 mi)
· Sponsor: GlaxoSmithKline
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
David Turbay, MD — El Paso, Texas (7.0 mi)
· Sponsor: Amgen
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — El Paso, Texas (7.0 mi)
· Sponsor: AstraZeneca
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Peripheral Arterial Disease
N/A
Observational 14,000 participants sought
El Paso Cardiovascular Care — El Paso, Texas (7.0 mi)
· Sponsor: Baylor Research Institute
rTMS for Military TBI-related Depression
Depressive Symptoms, Mild Traumatic Brain Injury
N/A
Interventional 198 participants sought
William Beaumont Army Medical Center — Fort Bliss, Texas (2.6 mi)
· Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
3A Research Llc West Location — El Paso, Texas (7.0 mi)
· Sponsor: Incyte Corporation
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
Alagille Syndrome
N/A
Observational 30 participants sought
Proactive El Paso,LLC — El Paso, Texas (7.0 mi)
· Sponsor: Ipsen
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Nephritis, Lupus, Lupus Erythematosus, Systemic
Phase 3
Interventional 300 participants sought
Texas Arthritis Center — El Paso, Texas (7.0 mi)
· Sponsor: Viatris Innovation GmbH
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Graves' Disease
Phase 2
Interventional 232 participants sought
Site 127 — El Paso, Texas (7.0 mi)
· Sponsor: Yarrow Bioscience, Inc.
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: Children's Oncology Group
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Proactive El Paso,LLC — El Paso, Texas (7.0 mi)
· Sponsor: Hoffmann-La Roche
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Hypertriglyceridemia
Phase 3
Interventional 869 participants sought
Research Site 27 — El Paso, Texas (7.0 mi)
· Sponsor: Arrowhead Pharmaceuticals
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 34 — El Paso, Texas (7.0 mi)
· Sponsor: Merus B.V.